Factors involved in the N-oxidation of isomeric aromatic diazines by microsomal preparations.

Drug Metabol Drug Interact

Chelsea Department of Pharmacy, King's College London, University of London, UK.

Published: April 1996

Factors affecting the metabolism of isomeric aromatic diazines in vitro were studied and the conditions which allow maximal metabolism established. The N-oxidation of isomeric diazines was linear with respect to microsomal concentration up to 0.5 g original liver weight per ml using a rabbit microsomal suspension. N-Oxidation was also linear up to between 20-30 minutes depending on substrate studied. The rate of N-oxide production increased with increase in substrate concentration up to about 10 mumol/incubate, after which the rate declined. By using the data obtained the appropriate kinetic factors, Km and Vmax, for the N-oxidation of pyrazine, pyrimidine and pyridazine by rabbit hepatic microsomal preparations were calculated. Spectral binding constants, Ks, of substrates to cytochrome P450 were also calculated and appeared to be related to the Km values.

Download full-text PDF

Source
http://dx.doi.org/10.1515/dmdi.1995.12.2.117DOI Listing

Publication Analysis

Top Keywords

n-oxidation isomeric
8
isomeric aromatic
8
aromatic diazines
8
microsomal preparations
8
factors involved
4
n-oxidation
4
involved n-oxidation
4
microsomal
4
diazines microsomal
4
preparations factors
4

Similar Publications

Feast-famine (FF) regimes improved the removal of recalcitrant pharmaceuticals in moving bed biofilm reactors (MBBRs), but the optimal FF cycle remained unresolved. The effects of FF cycle time on the removal of bulk substrates (organic carbon and nitrogen) and trace pharmaceuticals by MBBR are systematically evaluated in this study. The feast to famine ratio was fixed to 1:2 to keep the same loading rate, but the time for the FF cycles varied from 18 h to 288 h.

View Article and Find Full Text PDF

Citalopram (CIT) is one of the most consumed antidepressants and frequently detected in aquatic environments worldwide. Conventional wastewater treatment cannot remove this neuronal active pharmaceutical efficiently. Past studies showed that moving bed biofilm reactors (MBBRs) can degrade CIT but the exact transformation pathways and toxicity reduction remained unclear.

View Article and Find Full Text PDF

On the Ability of the N-O Bond to Support a Stable Stereogenic Axis: Peptide-Catalyzed Atroposelective -Oxidation.

J Org Chem

September 2023

Department of Chemistry, Yale University, 225 Prospect Street, New Haven, Connecticut 06520-8107, United States.

During studies of atroposelective, peptide-catalyzed -oxidations of pyridines, we observed lower-than-expected barriers to atropisomerization for these stereodynamic processes under the reaction conditions. Mechanistic studies indicate a hydrogen bond-assisted racemization mechanism intrinsic to both the starting materials and products. We also identified a protonation-dependent barrier to rotation that operates for the starting materials alone.

View Article and Find Full Text PDF

Complete H, C, and N assignments of the minor isomer of codeine N-oxide.

Magn Reson Chem

December 2022

Département de Recherche et Développement Pharmaceutique (DRDP), AP-HP, Agence Générale des Equipements et produits de Santé (AGEPS), Paris, France.

Codeine N-oxide 2 is an active metabolite of codeine obtained by oxidation and observed as a degradant in codeine drug products such as syrups. Oxidation of codeine's N-methyl function can deliver two regio-isomers due to chirality of the tetra-substituted nitrogen. Hydrogen peroxide oxidation of codeine was performed and induced two different isomers in a 9:1 ratio; these isomers were isolated using preparative high performance liquid chromatography (HPLC) and fully characterized by nuclear magnetic resonance (NMR) techniques.

View Article and Find Full Text PDF

Catalytic Enantioselective Synthesis of Pyridyl Sulfoximines.

J Am Chem Soc

June 2021

Department of Chemistry, Yale University, New Haven, Connecticut 06520-8107, United States.

With unique chemical and biological activity, sulfoximines have attracted enormous attention in the past decades, whereas limited reports exist for their synthesis via asymmetric catalysis. We report the synthesis of chiral sulfoximines through the desymmetrizing -oxidation of pyridyl sulfoximines using an aspartic acid-containing peptide catalyst. Various mono- and bis-pyridyl sulfoximine oxides are obtained with up to 99:1 er.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!